Oxford Financial Group’s CVS Health CVS Stock Holding History

Oxford Financial Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,370	Closed	-$212K	–	304
2024 Q3	$212K	Sell	3,370 -209	-6%	-$12.2K	0.01%	233
2024 Q2	$211K	Buy	3,579 +277	+8%	+$17.3K	0.01%	249
2024 Q1	$263K	Sell	3,302 -309	-9%	-$23.6K	0.02%	198
2023 Q4	$285K	Buy	3,611 +38	+1%	+$2.71K	0.02%	188
2023 Q3	$249K	Sell	3,573 -1,659	-32%	-$118K	0.02%	189
2023 Q2	$362K	Buy	5,232 +2,011	+62%	+$143K	0.03%	158
2023 Q1	$239K	Buy	+3,221	New	+$270K	0.03%	171
2022 Q3	–	Sell	-2,686	Closed	-$249K	–	248
2022 Q2	$249K	Buy	+2,686	New	+$262K	0.04%	168
2022 Q1	–	Sell	-2,052	Closed	-$212K	–	271
2021 Q4	$212K	Buy	+2,052	New	+$190K	0.02%	192
2021 Q2	–	Sell	-3,162	Closed	-$238K	–	228
2021 Q1	$238K	Buy	+3,162	New	+$230K	0.03%	159

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Oxford Financial Group's CVS Position: Q4 2024 in Review

Oxford Financial Group sold out of CVS Health (CVS) in Q4 2024, closing a stake of 3,370 shares — an estimated $212K sold.

Oxford Financial Group first reported a position in CVS in Q1 2021 and held it in 10 quarters. The position peaked at $362K in Q2 2023. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

Oxford Financial Group reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
Oxford Financial Group sold 3,370 CVS Health shares in Q4 2024, an estimated $212K.
Oxford Financial Group first reported a position in CVS Health in Q1 2021 and held it in 10 quarters.
Oxford Financial Group's CVS Health position peaked at $362K in Q2 2023.
1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Oxford Financial Group's 13F filing for Q4 2024, filed 11 Feb 2025.